These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23450666)

  • 1. Process analytical technology to understand the disintegration behavior of alendronate sodium tablets.
    Xu X; Gupta A; Sayeed VA; Khan MA
    J Pharm Sci; 2013 May; 102(5):1513-23. PubMed ID: 23450666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.
    Dansereau RJ; Crail DJ; Perkins AC
    Curr Med Res Opin; 2008 Apr; 24(4):1137-45. PubMed ID: 18334082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of alendronate to quality evaluation of tablets by high resolution ¹H NMR spectroscopy.
    Xie B; Liu A; Fang X; Chen Y; Zhong H
    J Pharm Biomed Anal; 2014 May; 93():73-6. PubMed ID: 24215933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
    Walker AD; Adachi JD
    Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro disintegration studies of weekly generic alendronate sodium tablets (70 mg) available in the US.
    Dansereau RJ; Crail DJ; Perkins AC
    Curr Med Res Opin; 2009 Feb; 25(2):449-52. PubMed ID: 19192989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disintegration/dissolution profiles of copies of Fosamax (alendronate).
    Epstein S; Cryer B; Ragi S; Zanchetta JR; Walliser J; Chow J; Johnson MA; Leyes AE
    Curr Med Res Opin; 2003; 19(8):781-9. PubMed ID: 14687450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach.
    Rajkumar AD; Reynolds GK; Wilson D; Wren S; Hounslow MJ; Salman AD
    Eur J Pharm Biopharm; 2016 Sep; 106():88-96. PubMed ID: 27287552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.
    Shakweh M; Bravo-Osuna I; Ponchel G
    Eur J Pharm Sci; 2007 Aug; 31(5):262-70. PubMed ID: 17576054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization.
    Szakonyi G; Zelkó R
    Int J Pharm; 2013 May; 448(2):346-53. PubMed ID: 23558313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro disintegration and dissolution and in vivo bioequivalence of two alendronate once-weekly formulations.
    Almeida S; Almeida A; Filipe A; Penedo C; Rocha A; Lainesse A; Vallée F
    Arzneimittelforschung; 2006; 56(2):84-9. PubMed ID: 16572922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
    Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the formation of hydrophobic ion-pairing complex of alendronate.
    You SK; Kwon HH; Lee JM; Shin SC; Cho CW
    Arch Pharm Res; 2009 Jul; 32(7):1055-60. PubMed ID: 19641887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising the disintegration properties of tablets in opaque media using texture analysis.
    Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
    Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.
    Zhao N; Augsburger LL
    AAPS PharmSciTech; 2005 Sep; 6(1):E120-6. PubMed ID: 16353956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone.
    Xi H; Ren J; Novak JM; Kemp E; Johnson G; Klinzing G; Johnson MA; Xu W
    Pharm Res; 2020 Mar; 37(4):70. PubMed ID: 32185516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH on disintegration and dissolution of ketoconazole tablets.
    Carlson JA; Mann HJ; Canafax DM
    Am J Hosp Pharm; 1983 Aug; 40(8):1334-6. PubMed ID: 6310994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.